Maternal Serum Screen 4; Quadruple Test in Pitampura & Rohini

MATERNAL SERUM SCREEN 4; QUADRUPLE TEST

Special Instruction: Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisition form is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks).

Parameters covered: 4

Report Frequency: Sample Mon through Sat by 9 am; Report Same day

MATERNAL SERUM SCREEN 4; QUADRUPLE – Overview

What is MATERNAL SERUM SCREEN 4; QUADRUPLE TEST ?

Maternal Serum Screen 4; Quadruple Test is a second-trimester prenatal screening blood test that estimates the risk of certain fetal conditions. It measures four maternal serum markers: Total β-hCG, Alpha-fetoprotein (AFP), Inhibin A, and Free Estriol. The results are assessed along with pregnancy-related information such as gestational age and maternal age. The test can help screen for increased risk of conditions such as Down syndrome, trisomy 18, and neural tube defects. It is a screening test, not a diagnostic test, so an abnormal result may require further evaluation.

Doctor Information

Pre-test Information

Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisition form is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks).

Report Delivery

Sample Mon through Sat by 9 am; Report Same day

Category

Prenatal Diagnosis

Stability Room

2 hrs

Stability Refrigerated

1 week

Stability Frozen

4 week

Method

CLIA

Specimen

3 mL (1.5 mL min.) Serum from 1 SST. Ship refrigerated or frozen.

Usage

Quadruple test is used for Prenatal Screening of Down Syndrome (Trisomy 21), Edward’s Syndrome (Trisomy 18) and Open Neural Tube Defects. The approximate detection rate with this test is 75-80 % with a false positive rate of 5%.

Maternal Serum Screen 4; Quadruple Test in Pitampura & Rohini for Second-Trimester Prenatal Screening

It analyzes a sample of maternal blood for four biochemical markers that indicate the presence of increased risks for certain developmental abnormalities in the fetus. Maternal Serum Screen 4; Quadruple Test in Pitampura is one of the options in second trimester screening when recommended by a medical practitioner.

The Bio Diagnostics mentions the following parameters: Total β-hCG, AFP, Inhibin A, and Free Estriol. The markers act collectively rather than individually as four different verdicts.

Maternal Serum Screen 4; Quadruple Test in Rohini: What Does It Check?

Maternal Serum Screen 4; Quadruple Test in Rohini tests for the presence of four markers in the maternal serum, which include alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol, and inhibin A. According to MedlinePlus, the quadruple test is usually done in the second trimester of pregnancy, between 15 and 22 weeks.

The markers include:

  • BHCG TOTAL (Total β-hCG)
  • AFP (Alpha-fetoprotein)
  • INHIBIN A
  • ESTRIOL, FREE (Free Estriol)

The test helps determine the risk of chromosomal disorders and neural tube defects.

How the Four Parameters Support Screening

Total β-hCG

Total β-hCG is a pregnancy hormone secreted by the placenta. In the quadruple screen, the amount of total β-hCG adds up to the total risk but not to the diagnosis.

AFP

AFP stands for alpha-fetoprotein, which is a protein that originates from the developing fetus. It plays a key role in detecting neural tube disorders.

Inhibin A

The level of Inhibin A is the fourth marker analyzed in a quadruple screen. The presence of the four markers is what makes it possible to calculate the risk.

Free Estriol

Free Estriol is a type of estrogen hormone that is related to pregnancy. It is among the four markers used in the maternal serum screening procedure.

When Is the Quadruple Test Done?

Maternal Serum Screen 4; Quad Screen in Pitampura is usually done in the second trimester of pregnancy. According to MedlinePlus, it is usually carried out from the 15th to the 22nd week, but its accuracy is usually optimal in a smaller range of the above-mentioned period.

Your physician might take into account gestational age, maternal age, history of pregnancy, ultrasound data, and prior screening results.

Proper timing is important because levels of markers fluctuate in the course of pregnancy.

What Can the Quadruple Screen Help Assess?

The Maternal Serum Screen 4 or the Quadruple Test in Rohini helps to predict the probability of some specific conditions in the fetus, such as Down’s syndrome (trisomy 21), trisomy 18, and some neural tube defects. However, it is important to note that it is a screening test, which means that the test is unable to confirm whether or not the fetus suffers from a certain disorder.

Even a high-risk or abnormal result does not necessarily indicate that something is wrong.

Quadruple Test vs Other Prenatal Screening

If you are comparing prenatal screening options, a Dual Marker Test in Pitampura and a Maternal Serum Screen 3; Triple Test in Pitampura may also come up during a discussion with your healthcare provider.

While the Triple Test involves three markers in the blood, the Quadruple Test includes inhibin A. Depending on the stage of pregnancy, there are different tests using different markers. Your doctor could assist you with choosing the right test for you.

Why Accurate Information Matters

Maternal Serum Screen 4 (Quadruple Test in Pitampura) is not just a test of four figures. It requires pregnancy dating, patient information, and the methodology of calculation in the laboratory to be evaluated.

At Bio Diagnostics, patients may consult their doctor about the test and realise that there is a need for clinical evaluation in order to interpret the screening test results. One number cannot serve as an interpretation of the test.

Simple Blood Test, Meaningful Risk Assessment

Maternal Serum Screen 4; Quadruple Screen at Rohini needs a sample of the mother’s blood. This process is similar to blood drawing where you might experience a slight sting of the needle.

According to MedlinePlus, there is no specific preparation required for this screen unless specified by your doctor or lab if the test is done along with other tests.

Understanding Your Result

It should be pointed out that a lower risk test does not mean the fetus is perfectly healthy and a higher risk test does not imply that the condition is present. According to MedlinePlus, there are instances of false positive and negative results that may require additional tests to be done.

Maternal Serum Screen 4; Quadruple Test in Pitampura can thus be seen as just one of many options for prenatal testing. Your obstetrician or another licensed medical professional will discuss the risk level with you.

Reliable Prenatal Screening Support

The quadruple test in Rohini is one of the options for second-trimester screening as advised by your healthcare professional. The four biomarkers include Total β-hCG, AFP, Inhibin A and Free Estriol.

In case you are advised to go for this screening procedure, it would be wise for you to go to a lab that has credibility in terms of testing and report generation. You can seek our assistance at Bio Diagnostics in Pitampura and Rohini.

Plan Your Prenatal Screening With Confidence

Maternal Serum Screen 4 (Quadruple Test) is advised in Pitampura. Please consult your doctor or visit the Bio Diagnostics for more information on test procedures and make an appointment right away.